Recently, the FDA-approved 18F-T807 (also known as 18F-AV-1451, 18F-flortaucipir, or TAUVID) showed promise as a cortical tau tracer in AD patients but not in non-AD tauopathies. The gene discussed is MAPT; the disease is Alzheimer disease.